Thailand aims to produce its own Covid-19 vaccine rather than waiting to buy inoculations from abroad, and human trials could start as early as October, according to the scientist leading one project.
“We learned a very painful lesson during the H1N1 pandemic when the government signed agreements to buy vaccines, but we didn’t get any until the outbreak was gone,” said Kiat Ruxrungtham, head researcher at Chulalongkorn University’s Center of Excellence in Vaccine Research and Development. “The pandemic is teaching the whole world to do something different.”
Blood results after the first injection in monkeys showed all generated antibodies, according to Kiat’s study. The majority also developed neutralizing antibodies, meaning the virus can be blocked from entering or damaging cells, he said. The second dose was injected this week, and Kiat said he expects results to pass the criteria needed for human trials.
Click here to read the full story on Bloomberg.com.